The restaurant chain doesn't issue guidance for fiscal 2022, but does say it expects commodity and wage inflation.
I'm downgrading FDX to a 'sell' and plan to exit the name.
Index charts all remain in near-term downtrends.
Let's take a look at Axsome Therapeutics and TG Therapeutics.
The gains are a game changer.
The shares soared into late August and then have corrected lower.
There are homes that could house an urban population of around 4 million now under construction by Evergrande alone.
I'm looking for a continuation of strong pockets of speculative action.
Like spilled milk, there is no use in crying over lost monetary opportunity that only increases economic risk at a bad time fiscally now.
When I first wrote about KNX it was under $44 -- look where it is now and what appears down the road for investors.